Health-Promoting Nature of Lactococcus lactis IBB109 and Lactococcus lactis IBB417 Strains Exhibiting Proliferation Inhibition and Stimulation of Interleukin-18 Expression in Colorectal Cancer Cells
Lactic acid bacteria (LAB) are Gram-positive bacteria which are considered for use as adjuvant therapeutics in management of various disease ailments, including obesity, irritable bowel syndrome, lactose intolerance and cancer. To investigate the possible use of Lactococcus lactis strains from our c...
Main Authors: | Przemysław Sałański, Magdalena Kowalczyk, Jacek K. Bardowski, Agnieszka K. Szczepankowska |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2022.822912/full |
Similar Items
-
In vitro assessment of hypocholesterolemic activity of Lactococcus lactis subsp. lactis
by: Mohamed G. Shehata, et al.
Published: (2019-04-01) -
Probiotic Lactococcus lactis: A Review
by: Priti Khemariya, et al.
Published: (2017-07-01) -
Production of alpha-interferon in Lactococcus lactis
by: Bayat, Omid
Published: (2013) -
Cloning of prochymosin gene in lactococcus lactis bacteria
by: L. Aminlari, et al.
Published: (2013-03-01) -
Characterization of a Lactococcus lactis promoter for heterologous protein production
by: Christian E. Ogaugwu, et al.
Published: (2018-03-01)